BTF acquired by bioMerieux

Friday, 14 September, 2007

Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.

The new acquisition will make BTF's products more accessible to a wider distribution network.

Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.

Related News

Evident names 5th Annual Image of the Year Award winners

View the six winning entries in Evident's 5th Annual Image of the Year Award — a...

Fellowships and scholarships support women in science

The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...

2024 GSK Award recognises neurodegeneration researcher

Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...

Content from other channels on our network

Calls for health-based approach to drug policy

DHCRC project to deliver benchmarking tool for AI in health

NHMRC announces new council

Cancer recurrence anxiety: clinical pathway for health professionals

Certain hormone treatments linked to increased heart disease risk

Maximising yield and minimising waste in dairy processing

Bird flu: No signs of the disease yet on Mainland's other NZ farms

Hygiena acquires Nexcor Food Safety Technologies

Six plant-based foods with brain-boosting benefits

NZ's Alliance Group uses AI tech for meat quality insights

Electrolyser manufacturing a $1.7 billion opportunity: report

Solar-powered desalination system requires no additional power

Fortescue awarded $10 million ARENA grant to develop fast charger

Building a critical infrastructure security dream team

Hazer secures $6.2 million WA Government grant

All content Copyright © 2024 Westwick-Farrow Pty Ltd